+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing Market - Global Forecast 2025-2030- Product Image
Pharmaceutical Contract Manufacturing Market - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Contract Manufacturing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968717
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical contract manufacturing market is entering a period of accelerated transformation, driven by shifts in technology adoption, evolving regulatory standards, and increased demand for customized therapies. Senior decision-makers now face a market landscape distinguished by complexity, interconnected challenges, and unprecedented opportunities for growth and innovation.

Market Snapshot: Pharmaceutical Contract Manufacturing Market

The Pharmaceutical Contract Manufacturing Market expanded from USD 123.64 billion in 2024 to USD 134.44 billion in 2025, and is forecasted to continue its upward trajectory with a CAGR of 8.49%, reaching USD 201.64 billion by 2030. This robust growth highlights the sector's ability to adapt quickly to shifting demand, notably in biologics, small molecule manufacturing, and personalized therapies. Strategic investments in technology, quality systems, and production scale are reshaping how service providers and pharmaceutical companies collaborate.

Scope & Segmentation

This report provides a comprehensive analysis of the pharmaceutical contract manufacturing market, focusing on the full spectrum of service offerings, molecule categories, dosage formats, customer types, contract structures, production scales, and operational processes. The research also explores the regional distribution of market activity and high-growth technology trends.

  • Service Types: Analytical services, development solutions, filling operations, manufacturing, and packaging & labeling support core industry needs.
  • Molecule Types: Biologics and small molecules form the main product groups, each with unique manufacturing demands.
  • Dosage Forms: Liquid and solid oral formulations, sterile injectables, and topical formats provide diverse patient administration routes.
  • Customer Types: Includes biosimilar developers, generic drug producers, and innovators requiring tailored manufacturing solutions.
  • Therapeutic Areas: Cardiovascular, CNS, infectious diseases, and oncology represent key drivers of outsourcing demand.
  • Contract Types: Dedicated and non-dedicated production models respond to a range of partnership needs.
  • Production Scales: Encompasses clinical trial phases (I–III) and commercial operations, each governed by distinct regulatory and operational criteria.
  • Process Types: Batch and continuous manufacturing approaches address varying needs for scalability and consistency.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, with specific focus on maturity, regulatory context, and emerging hotspots.
  • Key Technologies: Adoption of automation, digitalization, advanced analytics, real-time monitoring, and green chemistry practices are highlighted.

Key Takeaways for Senior Decision Makers

  • New regulatory frameworks are prompting contract manufacturers to enhance quality management and invest in upgraded compliance systems to meet global standards.
  • Rapid technological advances such as automation and digital platforms are being leveraged to improve operational efficiency, reduce lead times, and provide predictive maintenance for critical manufacturing assets.
  • The increasing complexity of biologics and personalized therapies is driving the need for specialized facilities and advanced analytical capabilities among service providers.
  • Strategic partnerships—including collaborations with analytical laboratories and academic institutions—are accelerating method development, technology transfer, and time to market for new therapies.
  • Market demand for sustainability is leading to wider adoption of waste minimization protocols and eco-friendly production practices.
  • Providers are focusing on flexible production suites and scalable capacity models to adapt quickly to both clinical and commercial project needs.

Tariff Impact: Navigating U.S. Policy Adjustments

Adjusted U.S. tariffs beginning in 2025 have directly impacted cost structures and supply chain models for pharmaceutical contract manufacturers. Procurement costs for raw materials and equipment are rising, requiring new sourcing strategies and investments in domestic production capabilities. Contract negotiations are increasingly favoring fixed pricing and risk-sharing models to manage volatility, while greater transparency in cost breakdowns and collaborative alliances are enhancing resilience amid ongoing trade fluctuations.

Methodology & Data Sources

This analysis integrates in-depth primary interviews with industry executives, regulatory experts, and process engineers; paired with secondary research including regulatory publications, market disclosures, and patent filings. Triangulation across multiple data sources and first-hand observations of manufacturing operations reinforce the reliability and granularity of insights delivered.

Why This Report Matters

  • Provides actionable strategic guidance for investment, technology adoption, and risk mitigation in an evolving global market.
  • Enables clear benchmarking of competitors, helping organizations anticipate emerging trends and regional distinctions in contract manufacturing operations.
  • Supports decision-making with a comprehensive segmentation analysis, aligning operational planning with current and forecasted market realities.

Conclusion

The contract manufacturing sector is evolving rapidly as technology, regulation, and global supply chain factors converge. Organizations that embrace digital integration, strategic partnerships, and flexible capacity are positioned for success. This research serves as a reliable guide for anticipating risks, pursuing opportunities, and navigating future transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for CDMOs providing fully integrated biologics development and manufacturing services
5.2. Rising adoption of continuous manufacturing technologies to enhance process efficiency and quality
5.3. Growing preference for small molecule API contract manufacturing adopting sustainable green chemistry practices
5.4. Expansion of personalized medicine requiring flexible contract manufacturing solutions for cell and gene therapies
5.5. Strategic partnerships between pharmaceutical firms and CDMOs to drive end-to-end process digitalization and automation
5.6. Implementation of advanced quality analytics and real-time process monitoring across outsourced production workflows
5.7. Regulatory harmonization across major markets increasing demand for CDMOs with comprehensive global compliance expertise
5.8. Surge in requests for sterile injectable contract manufacturing driven by vaccine and oncology supply chain priorities
5.9. Increased investment in single-use bioreactor technologies to accelerate biologics contract manufacturing scale-up timelines
5.10. Integration of AI-driven process optimization platforms into pharmaceutical contract manufacturing operations for yield improvement
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Contract Manufacturing Market, by Service Type
8.1. Introduction
8.2. Analytical Services
8.2.1. Bioanalytical Services
8.2.2. Method Development
8.2.3. Stability Studies
8.3. Development Services
8.3.1. Formulation Development
8.3.2. Process Development
8.4. Filling Services
8.4.1. Syringe Filling
8.4.2. Unit Dose Filling
8.4.3. Vial Filling
8.5. Manufacturing Services
8.5.1. Liquid Orals
8.5.2. Solid Oral Dosage
8.5.3. Sterile Injectables
8.5.4. Topical Formulations
8.6. Packaging & Labeling
8.6.1. Primary Packaging
8.6.2. Secondary Packaging
9. Pharmaceutical Contract Manufacturing Market, by Molecule Type
9.1. Introduction
9.2. Biologics
9.3. Small Molecule
10. Pharmaceutical Contract Manufacturing Market, by Dosage Form
10.1. Introduction
10.2. Liquid Dosage
10.2.1. Oral Solutions
10.2.2. Suspensions
10.3. Solid Dosage
10.3.1. Capsules
10.3.2. Tablets
10.4. Sterile Injectables
10.5. Topical Dosage
10.5.1. Creams & Ointments
10.5.2. Gels
11. Pharmaceutical Contract Manufacturing Market, by Customer Type
11.1. Introduction
11.2. Biosimilar Manufacturers
11.3. Generic Manufacturers
11.4. Innovator Manufacturers
12. Pharmaceutical Contract Manufacturing Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular
12.3. CNS
12.4. Infectious Diseases
12.5. Oncology
13. Pharmaceutical Contract Manufacturing Market, by Contract Type
13.1. Introduction
13.2. Dedicated
13.3. Non Dedicated
14. Pharmaceutical Contract Manufacturing Market, by Production Scale
14.1. Introduction
14.2. Clinical Trial
14.2.1. Phase I
14.2.2. Phase II
14.2.3. Phase III
14.3. Commercial
15. Pharmaceutical Contract Manufacturing Market, by Process Type
15.1. Introduction
15.2. Batch
15.3. Continuous
16. Americas Pharmaceutical Contract Manufacturing Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Pharmaceutical Contract Manufacturing Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Lonza Group AG
19.3.2. Catalent, Inc.
19.3.3. Thermo Fisher Scientific Inc.
19.3.4. Samsung Biologics Co., Ltd.
19.3.5. Wuxi AppTec Co., Ltd.
19.3.6. Fujifilm Diosynth Biotechnologies US, LLC
19.3.7. Recipharm AB
19.3.8. Siegfried Holding AG
19.3.9. Cambrex Corporation
19.3.10. PCI Pharma Services, Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCHAI
FIGURE 32. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 33. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 34. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYRINGE FILLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYRINGE FILLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY UNIT DOSE FILLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY UNIT DOSE FILLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY VIAL FILLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY VIAL FILLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID ORALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID ORALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID ORAL DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID ORAL DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INNOVATOR MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INNOVATOR MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEDICATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEDICATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY NON DEDICATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY NON DEDICATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 209. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 210. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 211. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 212. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 213. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 214. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 215. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2024 (USD MILLION)
TABLE 216. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2025-2030 (USD MILLION)
TABLE 217. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 218. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 219. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 220. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 221. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 226. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 227. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 228. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 229. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2024 (USD MILLION)
TABLE 230. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2025-2030 (USD MILLION)
TABLE 231. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 232. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 233. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 234. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 235. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 236. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 237. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 238. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 239. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2024 (USD MILLION)
TABLE 240. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2025-2030 (USD MILLION)
TABLE 241. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 242. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2018-2024 (USD MILLION)
TABLE 250. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FILLING SERVICES, 2025-2030 (USD MILLION)
TABLE 251. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 254. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 255. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 258. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 259. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TOPICAL DOSAGE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 268. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 269. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2018-2024 (USD MILLION)
TABLE 270. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2025-2030 (USD MILLION)
TABLE 271. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 272. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 273. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2018-2024 (USD MILLION)
TABLE 274. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL, 2025-2030 (USD MILLION)
TABLE 275. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 276. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DEVELOPMENT SERVICES, 2018-2024

Samples

Loading
LOADING...

Companies Mentioned

  • Lonza Group AG
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Samsung Biologics Co., Ltd.
  • Wuxi AppTec Co., Ltd.
  • Fujifilm Diosynth Biotechnologies US, LLC
  • Recipharm AB
  • Siegfried Holding AG
  • Cambrex Corporation
  • PCI Pharma Services, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 134.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 201.64 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmaceutical Contract Manufacturing & Research Services Market - Global Forecast 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing & Research Services Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Pharmaceutical CDMO & Contract Manufacturing Services Market - Global Forecast 2025-2030 - Product Image

Pharmaceutical CDMO & Contract Manufacturing Services Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 178 Pages
  • Global
From
Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of Primary Packaging Container, Scale of Operation and Leading Players - Product Image

Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of Primary Packaging Container, Scale of Operation and Leading Players

  • Report
  • Global
From

About the Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing (PCM) is a type of pharmaceutical manufacturing in which a company outsources the production of a drug or medical device to a third-party manufacturer. This type of manufacturing is often used when a company does not have the resources or expertise to produce a product in-house. PCM can also be used to reduce costs, increase production capacity, and improve product quality. PCM services can include formulation development, process optimization, analytical testing, packaging, and labeling. The contract manufacturer is responsible for ensuring that the product meets all regulatory requirements and is of the highest quality. Some of the major players in the PCM market include Patheon, Catalent, Recipharm, Aenova, and Vetter. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.